Table 3.

Adverse events

Adverse event	Incidence, n (%)
	Grade 1	Grade 2	Grade 3	Grade 4
Neutropenia	8 (27.6)	8 (27.6)	4 (13.8)	4 (13.8)
Febrile neutropenia	1 (13.8)	0 (0.0)	0 (0.0)	0 (0.0)
Anemia	9 (31.03%)	1 (3.5%)	0 (0.0)	0 (0.0)
Thrombocytopenia	4 (13.8%)	3 (10.3%)	0 (0.0)	0 (0.0)
ALT elevation	1 (3.5%)	2 (6.9%)	0 (0.0)	0 (0.0)
TBIL elevation	2 (6.9%)	1 (3.5%)	0 (0.0)	0 (0.0)
Hair loss	9 (31.03%)	2 (6.9%)	0 (0.0)	0 (0.0)
Fatigue	3 (10.3%)	3 (10.3%)	0 (0.0)	0 (0.0)
Hand–foot syndrome	0 (0.0)	3 (10.3%)	1 (3.5%)	0 (0.0)
Peripheral neuropathy	4 (13.8%)	0 (0.0)	0 (0.0)	0 (0.0)
Anorexia	16 (55.2%)	4 (13.8%)	0 (0.0)	0 (0.0)
Nausea	14 (48.3%)	6 (20.7%)	0 (0.0)	0 (0.0)
Vomiting	5 (17.2%)	2 (6.9%)	0 (0.0)	0 (0.0)
Stomatitis	0 (0.0)	2 (6.9%)	0 (0.0)	0 (0.0)
Diarrhea	2 (6.9%)	1 (3.5%)	2 (6.9%)	0 (0.0)
Rash	2 (6.9%)	0 (0.0)	1 (3.5%)	0 (0.0)